ReviewBiological research2026

Telomerase as a therapeutic Bullseye: advances in cancer treatment and clinical trials : A comprehensive review of small molecule inhibitors, antisense oligonucleotides, and immunotherapeutic strategies targeting the telomerase catalytic subunit (hTERT).

Ansar Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.